How do you… decide which platelet bacterial risk mitigation strategy to select for your hospital‐based transfusion service?-Reference-Cited by-同舟云学术

How do you… decide which platelet bacterial risk mitigation strategy to select for your hospital‐based transfusion service?

Published:2020-02-06 Issue:4 Volume:60 Page:675-681
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Lu Wen¹^ORCID,Delaney Meghan²,Flegel Willy A.³^ORCID,Ness Paul⁴,Ratcliffe Nora⁵,Triulzi Darrell J.⁶,Yazer Mark H.⁶^ORCID,Ziman Alyssa⁷,Dunbar Nancy M.⁸^ORCID

Affiliation:

1. Robert Tomsich Pathology & Laboratory Medicine InstituteCleveland Clinic Cleveland Ohio

2. Pathology and Laboratory MedicineChildrenʼs National Medical Center Washington DC

3. Department of Transfusion Medicine, NIH Clinical CenterNational Institutes of Health Bethesda Maryland

4. Department of PathologyJohns Hopkins University School of Medicine Baltimore Maryland

5. Pathology & Laboratory MedicineWhite River Junction VA Medical Center White River Junction Vermont

6. Centralized Transfusion ServiceUniversity of Pittsburgh Pittsburgh Pennsylvania

7. Wing‐Kwai and Alice Lee‐Tsing Chung Transfusion Service, Department of Pathology and Laboratory Medicine, David Geffen School of MedicineUniversity of California Los Angeles Los Angeles California

8. Department of Pathology and Laboratory MedicineDartmouth Hitchcock Medical Center Lebanon New Hampshire

Funder

NIH Clinical Center at the National Institutes of Health

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15693

Reference24 articles.

1. U.S. Food & Drug Administration. Fatalities reported to FDA following blood collection and transfusion – annual summary for fiscal year 2017. [cited 2019 Nov 15]. Available from:https://www.fda.gov/media/124796/download.

2. U.S. Food & Drug Administration. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion [Internet]. [cited 2019 Nov 15]. Available from:https://www.fda.gov/media/123448/download.

3. Swan E. Solution selection matrix [Internet]. [cited 2019 Nov 26]. Available from:https://goleansixsigma.com/solution-selection-matrix/.

4. Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions

5. Pathogen Inactivation Technologies

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transfusion Support in Hematopoietic Stem Cell Transplantation: A Contemporary Narrative Review;Clinical Hematology International;2024-03-25

2. Neonatal Blood Banking Practices;Clinics in Perinatology;2023-12

3. Pathogen‐reduced platelets in pediatric and neonatal patients: Demographics, transfusion rates, and transfusion reactions;Transfusion;2021-08-27

4. Neonatal and pediatric blood bank practice in the United States : Results from the AABB pediatric transfusion medicine subsection survey;Transfusion;2021-06-10